Form 4 for PRVA Privia Health Group, Inc.
Accepted 2025-05-14 00:00:00 ET · period of report 2025-05-12 · accession 0001759655-25-000053 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-14 | 2025-05-12 | PRVA | Mountcastle David | EVP, CFO | S - Sale | $24.99 | -3,322 | 172.9K | -2% | -$83.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.01 per share | 2025-05-12 | S | D | 3,322 | $24.99 | 172,909 | D | — | — | (F1) The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to a sell to cover transaction to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units. |